Akums Drugs

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE09XN01023
  • NSEID: AKUMS
  • BSEID: 544222
INR
620.50
2.95 (0.48%)
BSENSE

Jun 23, 03:05 PM

BSE+NSE Vol: 2.69 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
30.62
30.62
28.61
28.61
14.31
1.30
Share Warrants & Outstandings
Total Reserve
3,282.73
3,016.39
680.88
688.58
607.67
883.55
Shareholder's Funds
3,313.35
3,047.01
709.50
717.19
621.98
884.85
Minority Interest
17.77
16.60
10.99
0.00
0.00
0.00
Long-Term Borrowings
0.00
0.00
78.30
115.50
13.33
1.16
Secured Loans
0.00
0.00
78.30
115.50
13.33
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
1.16
Deferred Tax Assets / Liabilities
-153.18
-189.45
-110.91
-6.22
20.45
26.57
Other Long Term Liabilities
954.77
101.57
1463.85
1110.56
1094.9
636.91
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
48.61
35.90
31.02
26.23
23.93
20.44
Total Non-Current Liabilities
850.20
-51.98
1,462.26
1,246.07
1,152.61
685.08
Current Liabilities
Trade Payables
602.16
642.78
532.13
567.14
589.67
341.41
Other Current Liabilities
354.22
180.10
208.56
231.01
279.21
86.02
Short Term Borrowings
72.95
13.65
413.26
421.48
344.62
95.90
Short Term Provisions
65.42
57.21
56.60
45.94
58.92
56.62
Total Current Liabilities
1,094.76
893.75
1,210.55
1,265.57
1,272.42
579.95
Total Liabilities
5,276.08
3,905.38
3,393.30
3,235.01
3,050.20
2,152.17
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
2,241.10
2,054.53
1,752.84
1,540.87
1,428.76
1,245.09
Less: Accumulated Depreciation
954.15
818.64
679.27
569.92
489.28
411.29
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
1,286.95
1,235.88
1,073.57
970.95
939.48
833.80
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
176.66
159.62
195.13
102.99
30.82
17.00
Intangible assets under development
0.73
3.17
0.28
0.16
0.25
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.14
0.14
0.14
0.14
0.39
0.53
Long Term Loans & Advances
75.91
61.56
56.52
96.45
88.80
50.55
Other Non Current Assets
6.97
8.91
9.58
59.07
45.34
22.68
Total Non-Current Assets
1,716.22
1,630.77
1,452.42
1,356.14
1,186.13
994.76
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00
0.00
19.01
Inventories
755.71
680.93
630.42
729.79
722.45
429.86
Sundry Debtors
796.56
770.30
833.81
845.09
884.31
531.40
Cash and Bank
1,680.60
576.45
277.05
149.99
102.85
67.87
Other Current Assets
52.18
61.33
31.97
40.32
29.40
23.84
Short Term Loans and Advances
274.80
185.60
167.63
113.68
125.06
85.43
Total Current Assets
3,559.86
2,274.61
1,940.88
1,878.87
1,864.06
1,157.40
Net Current Assets (Including Current Investments)
2,465.10
1,380.86
730.33
613.30
591.64
577.45
Total Current Assets Excluding Current Investments
3,559.86
2,274.61
1,940.88
1,878.87
1,864.06
1,138.40
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
5,276.08
3,905.38
3,393.30
3,235.01
3,050.20
2,152.17
Contingent Liabilities
99.40
91.90
88.62
81.54
97.51
22.49
Total Debt
72.95
13.65
491.56
536.97
357.95
97.06
Book Value per share (adjusted)
0
199.01
49.59
50.13
43.475
1360.256
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2026 is 434.43% vs -97.22% in Mar 2025

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2026 is 840.01% vs -93.06% in Mar 2025

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2026 is 4.88% vs 9.99% in Mar 2025

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Mar 2026 is 56.50% vs 17.19% in Mar 2025

Compare Balance Sheet Results of Akums Drugs
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
30.62
11.98
18.64
155.59%
Share Warrants & Outstandings
Total Reserve
3,282.73
481.12
2,801.61
582.31%
Shareholder's Funds
3,313.35
493.09
2,820.26
571.96%
Minority Interest
17.77
0.00
17.77
0.00%
Long-Term Borrowings
0.00
39.55
-39.55
-100.00%
Secured Loans
0.00
39.55
-39.55
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-153.18
6.03
-159.21
-2,640.30%
Other Long Term Liabilities
954.77
1.66
953.11
57,416.27%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
48.61
1.75
46.86
2,677.71%
Total Non-Current Liabilities
850.20
49.00
801.20
1,635.10%
Current Liabilities
Trade Payables
602.16
60.48
541.68
895.63%
Other Current Liabilities
354.22
17.68
336.54
1,903.51%
Short Term Borrowings
72.95
95.70
-22.75
-23.77%
Short Term Provisions
65.42
0.90
64.52
7,168.89%
Total Current Liabilities
1,094.76
174.76
920.00
526.44%
Total Liabilities
5,276.08
716.85
4,559.23
636.01%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
2,241.10
202.23
2,038.87
1,008.19%
Less: Accumulated Depreciation
954.15
24.95
929.20
3,724.25%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
1,286.95
177.28
1,109.67
625.94%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
176.66
88.22
88.44
100.25%
Intangible assets under development
0.73
0.00
0.73
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.14
0.00
0.14
0.00%
Long Term Loans & Advances
75.91
14.84
61.07
411.52%
Other Non Current Assets
6.97
0.33
6.64
2,012.12%
Total Non-Current Assets
1,716.22
292.73
1,423.49
486.28%
Current Assets Loans & Advances
Current Investments
0.00
0.14
-0.14
-100.00%
Inventories
755.71
128.67
627.04
487.32%
Sundry Debtors
796.56
185.35
611.21
329.76%
Cash and Bank
1,680.60
51.81
1,628.79
3,143.78%
Other Current Assets
52.18
40.33
11.85
29.38%
Short Term Loans and Advances
274.80
17.82
256.98
1,442.09%
Total Current Assets
3,559.86
424.12
3,135.74
739.35%
Net Current Assets (Including Current Investments)
2,465.10
249.36
2,215.74
888.57%
Total Current Assets Excluding Current Investments
3,559.86
423.98
3,135.88
739.63%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
5,276.08
716.85
4,559.23
636.01%
Contingent Liabilities
99.40
0.10
99.30
99,300.00%
Total Debt
72.95
0.00
72.95
0.00%
Book Value per share (adjusted)
0.00
50.48
-50.48
-100.00%
Annual - Borrowings
Borrowings 72.95 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 434.43% vs -97.22% in Mar 2025

Annual - Other Long Term Liabilities
Other Long Term Liabilities 954.77 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 840.01% vs -93.06% in Mar 2025

Annual - Fixed Assets
Fixed Assets 1,463.62 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 4.88% vs 9.99% in Mar 2025

Annual - Investments
Investments 0.14 Cr
in Mar 2026

Figures in Cr
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 3,559.86 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 56.50% vs 17.19% in Mar 2025